MiMedx Group, Inc. Accounts Receivable, Allowance for Credit Loss, Current
MiMedx Group, Inc. (MDXG) had Accounts Receivable, Allowance for Credit Loss, Current of $14.80 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2026-07-29
- 2026-06-30: Accounts Receivable, Allowance for Credit Loss, Current $14.80M.
- 2026-03-31: Accounts Receivable, Allowance for Credit Loss, Current $9.54M.
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss, Current $8.70M.
- 2025-09-30: Accounts Receivable, Allowance for Credit Loss, Current $5.42M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.80M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $9.54M 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $8.70M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $5.42M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $3.94M 10-Q · filed 2026-07-29 | |
| 2025-03-31 | $3.87M 10-Q · filed 2026-07-29 | |
| 2024-12-31 | $3.13M 10-Q · filed 2026-07-29 | |
| 2024-09-30 | $2.77M 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $3.27M 10-Q · filed 2025-10-29 | |
| 2024-03-31 | $3.27M 10-Q · filed 2025-10-29 | |
| 2023-12-31 | $3.14M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $2.57M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $2.20M 10-Q · filed 2024-10-30 | |
| 2023-03-31 | $3.60M 10-Q · filed 2024-07-31 | |
| 2022-12-31 | $3.78M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $3.83M 10-Q · filed 2023-10-30 | |
| 2022-06-30 | $3.47M 10-Q · filed 2023-10-30 | |
| 2022-03-31 | $1.39M 10-Q · filed 2023-08-01 | $1.39M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $1.19M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $867.00K 10-Q · filed 2021-11-02 | |
| 2020-12-31 | $737.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |